DURATOCIN

This brand name is authorized in Canada, Ecuador, Hong Kong SAR China, New Zealand, Singapore.

Active ingredients

The drug DURATOCIN contains one active pharmaceutical ingredient (API):

1	Carbetocin UNII 88TWF8015Y - CARBETOCIN
	Carbetocin selectively binds to oxytocin receptors in the smooth muscle of the uterus, stimulates rhythmic contractions of the uterus, increases the frequency of existing contractions, and raises the tone of the uterus musculature.
	Read more about Carbetocin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DURATOCIN Solution for injection	MPI, CA: SPM	Health Products and Food Branch (CA)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H01BB03	Carbetocin	H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01B Posterior pituitary lobe hormones → H01BB Oxytocin and analogues
Discover more medicines within H01BB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02231593, 02496526
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	3136-MEE-1217
HK	Department of Health Drug Office	50670
NZ	Medicines and Medical Devices Safety Authority	11156
SG	Health Sciences Authority	12401P, 15173P